Effect and mechanism of jianpishengxue tablet on renal anemia

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18 to 75 years;
•2. Gender: Male or female;
•3. Hemoglobin was lower than normal but > 90g/L, and TSAT < 25% and ferritin < 200µg/L;
•4. Patients with chronic kidney disease and non-dialysis.

•1. Those who had used intravenous iron, oral iron or EPO within one month before inclusion;
•2. Suffer from hemochromatosis or hemosiderosis;
•3. Suffer from acute or chronic infectious diseases (such as cold, hepatitis, etc.), tumors, and diseases of the blood system;
•4. Patients with peptic ulcer, ulcerative enteritis, pancreatitis, intestinal inflammation and alcoholism;
•5. Patients who are allergic to or have allergies to this drug;
•6. Poor nutritional status within one month before enrollment;
•7. Patients undergoing other intervention clinical studies at the same time;
•8. Pregnant women and lactating women.

发起方

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology